Selected nutraceutic screening by therapeutic effects on doxorubicin-induced chronic kidney disease.
Abstract
SCOPE
The number of patients with chronic kidney disease (CKD) are increasing. Interventions such as controlling hypertension and
specific pharmacologic options are recommended. Some nutraceutics may have benefits in this regard.
METHODS AND RESULTS
Naringenin (a flavanon), catechin (a flavanol), and quercetin (a flavonol) and rutin (a flavonol rutinoside) were tried on
CKD in a Sprague Dawley rat model. Results indicated quercetin to be the most effective therapeutic candidate with respect
to renal edema, hypertension, serum creatinine, hematocrit, cardiopathy, aorta calcification, glomerular amyloidosis, erythrocyte
depletion in bone marrow, collagen deposition, expressions of TNF-α, cleaved caspase-3, IκBα, PPARα, and serum insulin. But
quercetin was only partially effective in restoring glomerular filtration rate, albuminuria, serum cholesterol, triglyceride,
blood urea nitrogen (BUN), uric acid, malondialdehyde, superoxide dismutase; urinary BUN and urinary creatinine. As for signaling,
quercetin was completely effective in alleviating the cleaved caspase-3, being only partially effective in suppressing Bax
and Bad, restoring Bcl-2, and rescuing DNA damage.
CONCLUSION
The CKD status cannot to be ameliorated by naringenin, rutin, and catechin. Comparatively, quercetin may be a better therapeutic
candidate.
Links
Authors
Peng CC, Hsieh CL, Ker YB, Wang HY, Chen KC, Peng RY
Institution
Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Source
Molecular nutrition & food research 56:10 2012 Oct pg 1541-58MeSH
AlbuminuriaAnimals
Blood Urea Nitrogen
Caspase 3
Catechin
Cholesterol
Creatinine
Dietary Supplements
Doxorubicin
Flavanones
Glomerular Filtration Rate
In Situ Nick-End Labeling
Insulin
Kidney
Male
Malondialdehyde
Oxidative Stress
PPAR alpha
Quercetin
Rats
Rats, Sprague-Dawley
Renal Insufficiency, Chronic
Rutin
Superoxide Dismutase
Triglycerides
Uric Acid
bcl-2-Associated X Protein
bcl-Associated Death Protein
Pub Type(s)
Journal ArticleResearch Support, Non-U.S. Gov't
Language
eng
PubMed ID
22945467
Log In

